For the Inventor, By the Inventor

Enter assignee name

Marseilles, France

Assistance Publique Hopitaux De Marseille

USPTO Granted Patents = 15

EPO Patents = 28

Forward Citations = 5

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

Françoise Dignat-George (4 out of 6 patents)

Didier Raoult (3 out of 19 patents)

Nathalie Bardin (3 out of 5 patents)

4. Marcel Blot-Chabaud (3 out of 5 patents)

5. Jean-Marc Rolain (2 out of 2 patents)

6. Benjamin Guillet (2 out of 4 patents)

7. Vincent Garitey (2 out of 3 patents)

8. Pierre Cau (2 out of 3 patents)

9. Nicolas Levy (2 out of 5 patents)

10. Carlos Lopez-Otin (2 out of 2 patents)

11. Yves Simon Alimi (2 out of 3 patents)

12. Stefan Enoch (1 out of 5 patents)

13. Redha Abdeddaim (1 out of 3 patents)

14. Éric Émile David Guedj (1 out of 1 patent)

15. Raphaëlle Richieri Le Rouzic (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 12496180 - Vascular prosthesis (2025-12-16),

2. 12411143 - CD146 and uses thereof as a biomarker and as a therapeutic target in the diagnosis and treatment of fibrosis (2025-09-09),

3. 11466261 - Mutated PTE enzymes (2022-10-11),

4. 11427648 - Anti-CD146 antibodies and uses thereof (2022-08-30),

5. 11278733 - Magnetic emission device for non-invasive cerebral magnetic stimulation (2022-03-22),

6. 11091735 - Polyvalent culture medium for anaerobic bacteria under aerobic conditions (2021-08-17),

7. 10837044 - Automated method for analyzing and interpreting an antimicrobial susceptibility (2020-11-17),

8. 10809269 - Use of soluble CD146 as a biomarker to select in vitro-fertilized embryo for implantation in a mammal (2020-10-20),

9. 10716572 - Blood flow reducer and method using the same (2020-07-21),

10. 9700051 - Use of squalamine or analogue as a disinfecting agent (2017-07-11),

11. 9598499 - Antigen binding formats for use in therapeutic treatments or diagnostic assays (2017-03-21),

12. 9072757 - Combination of an HMG-CoA reductase inhibitor and a farnesyl-pyrophosphate synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins (2015-07-07),

13. 8864810 - Device for implanting a vascular prosthesis (2014-10-21),

14. 8541189 - Method for measuring the plasmine activity of microparticles present in a sample of blood or a blood component (2013-09-24),

15. 8518914 - HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells (2013-08-27),

Assistance Publique Hopitaux De Marseille is the leading hospital group in the Marseille region, providing high-quality healthcare services to patients. With a strong team of medical professionals and state-of-the-art facilities, the hospital strives to deliver excellent patient care and promote wellness in the community.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

15 Patents

#6 in Marseilles

#1,229 in France

#38,742 in the World

Marseilles, France

Assistance Publique Hopitaux De Marseille

Forward Citations = 5

52 inventors:

Françoise Dignat-George (4 out of 6 patents)

Didier Raoult (3 out of 19 patents)

Nathalie Bardin (3 out of 5 patents)

4. Marcel Blot-Chabaud (3 out of 5 patents)

5. Jean-Marc Rolain (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…